Induction of Dopaminergic Neurons From Human Wharton's Jelly Mesenchymal Stem Cell by Forskolin

Journal of Cellular Physiology

Volumn 229, Issue 2, 2014, Pages 232-244

  Paldino, Emanuela ^a   Cenciarelli, Carlo ^b   Giampaolo, Adele ^c   Milazzo, Luisa ^c   Pescatori, Mario ^d,e   Hassan, Hamisa Jane ^c   Casalbore, Patrizia ^a  

^a CNR   (Italy)

^b INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e Health e solutions   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; DOPAMINE TRANSPORTER; ENDOGLIN; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NESTIN; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN TYROSINE KINASE A; THY 1 ANTIGEN; TRANSCRIPTION FACTOR SOX2;

ADHERENT CELL; ADIPOGENESIS; ANTIGEN DETECTION; ARTICLE; BONE DEVELOPMENT; BRAIN CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; WESTERN BLOTTING; WHARTON JELLY;

CARDIOTONIC AGENTS; CELL DIFFERENTIATION; CELLS, CULTURED; COLFORSIN; DOPAMINERGIC NEURONS; GENE EXPRESSION REGULATION; HUMANS; MESENCHYMAL STROMAL CELLS; NEURONS; SIGNAL TRANSDUCTION;

EID: 84886305692     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24442     Document Type: Article

References (40)

1. Baglio SR, Pegtel DM, Baldini N. 2012. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell free therapy. Front Physiol 3:359.
2. Bartkowska K, Paquin A, Gauthier AS, Kaplan DR, Miller FD. 2007. Trk signaling regulates neural precursor cell proliferation and differentiation during cortical development. Development 134:4369-4380.
3. Battula VL, Bareiss PM, Treml S, Conrad S, Albert I, Hojak S, Abele H, Schewe B, Just L, Skutella T, Bühring HJ. 2007. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75:279-291.
4. Conconi MT, Di Liddo R, Tommasini M, Calore C, Parnigotto PP. 2011. Phenotype and differentiation potential of stromal populations obtained from various zones of human umbilical cord: An overview. J Tissue Eng Regen M 4:6-20.
5. Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG. 2011. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells. Cytotherapy 13:918-932.
6. Deogracias R, Espliguero G, Iglesias T, Rodríguez-Peña A. 2004. Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons. Mol Cell Neurosci 26:470-480.
7. Deuse T, Stubbendorff M, Tang-Quan K, Phillips N, Kay MA, Eiermann T, Phan TT, Volk HD, Reichenspurner H, Robbins RC, Schrepfer S. 2011. Immunogenecity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells. Cell Transplant 20:655-667.
8. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
9. Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A. 2011. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep 7:1-16.
10. Fu YS, Shih YT, Cheng YC, Min MY. 2004. Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 11:652-660.
11. Gauthaman K, Fong CY, Suganya CA, Subramanian A, Biswas A, Choolani M, Bongso A. 2012. Extra embryonic human Wharton's jelly stem cells do not induce tumorigenesis, unlike human embryonic stem cells. Reprod Biomed Online 24:235-246.
12. Hanson MG, Jr., Shen S, Wiemelt AP, McMorris FA, Barres BA. 1998. Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18:7361-7371.
13. Huang YC, Parolini O, La Rocca G, Deng L. 2012. Umbilical cord versus bone marrow derived mesenchymal stromal cells. Stem Cells Dev 21:2900-2903.
14. Juliandi B, Abematsu M, Nakashima K. 2010. Chromatin remodeling in neural stem cell differentiation. Curr Opin Neurobiol 20:408-415.
15. Kamachi Y, Uchikawa M, Kondoh H. 2000. Pairing SOX off: With partners in the regulation of embryonic development. Trends Genet 16:182-187.
16. Kocsis JD, Honmou O. 2012. Bone marrow stem cells in experimental stroke. Prog Brain Res 201:79-98.
17. Kranz A, Wagner DC, Kamprad M, Scholz M, Schmidt UR, Nitzsche F, Aberman Z, Emmrich F, Riegelsberger UM, Boltze J. 2010. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 1315:128-136.
18. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasà L, Cappello F, Zummo G, Farina F. 2009. Isolation and characterization of OCT4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: Differentiation potential and detection of new markers. Histochem Cell Biol 131:267-282.
19. Laroni A, Novi G, Kerlero de Rosbo N, Uccelli A. 2013. Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. J Neuroimmune Pharmacol. DOI: 10.1007/S11 481-013-9456-6
20. Liang J, Wu S, Zhao H, Li SL, Liu ZX, Wu J, Zhou L. 2013. Human umbilical cord mesenchymal stem cells derived from Wharton's jelly differentiate into cholinergic-like neurons in vitro. Neurosci Lett 532:59-63.
21. Ma L, Feng XY, Cui BL, Law F, Jiang XW, Yang LY, Xie QD, Huang TH. 2005. Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin Med J 118:1987-1993.
22. Michel PP, Agid Y. 1996. Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons. J Neurochem 67:1633-1642.
23. Mitchell KE, Weiss ML, Mitchell BM, Martin P, Davis D, Morales L, Helwig B, Beerenstrauch M, Abou-Easa K, Hildreth T, Troyer D, Medicetty S. 2003. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 21:50-60.
24. Murer MG, Raisman-Vozari R, Yan Q, Ruberg M, Agid Y, Michel PP. 1999. Survival factors promote BDNF protein expression in mesencephalic dopaminergic neurons. Neuroreport 10:801-805.
25. Nichols J, Zevnik B, Anastassiadis K, Niwa H, Klewe-Nebenius D, Chambers I, Scholer H, Smith A. 1998. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95:379-391.
26. Otsuru S, Gordon PL, Shimono K, Jethva R, Marino R, Phillips CL, Hofmann TJ, Veronesi E, Dominici M, Iwamoto M, Horwitz EM. 2012. Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. Blood 120:1933-1941.
27. Peng J, Wang Y, Zhang L, Zhao B, Zhao Z, Chen J, Guo Q, Liu S, Sui X, Xu W, Lu S. 2011. Human umbilical cord Wharton's jelly-derived mesenchymal stem cells differentiate into a Schwann-cell phenotype and promote neurite outgrowth in vitro. Brain Res Bull 84:235-243.
28. Peng C, Aron L, Klein R, Li M, Wurst W, Prakash N, Le W. 2011. Pitx3 is a critical mediator of GDNF-induced BDNF expression in nigrostriatal dopaminergic neurons. J Neurosci 31:12802-12815.
29. Pevny L, Placzek M. 2005. SOX genes and neural progenitor identity. Curr Opin Neurobiol 15:7-13.
30. Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB. 2010. Pro-inflammatory cytokines, IFNγ and TNFα, influence immune properties of human bone marrow and Wharton's jelly mesenchymal stem cells differentially. PLoS ONE 5:e9016.
31. Schwartz PH, Brick DJ, Stover AE, Loring JF, Müller FJ. 2008. Differentiation of neural lineage cells from human pluripotent stem cells. Methods 45:142-158.
32. Tipnis S, Viswanathan C, Majumdar AS. 2010. Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: Role of B7-H1 and IDO. Immunol Cell Biol 88:795-806.
33. Tomioka M, Nishimoto M, Miyagi S, Katayanagi T, Fukui N, Niwa H, Muramatsu M, Okuda A. 2002. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 30:3202-3213.
34. Tsai RYL, McKay RDG. 2000. Cell contact regulates fate choice by cortical stem cells. J Neurosci 20:3725-3735.
35. Wakabayashi K, Nagai A, Sheikh AM, Shiota Y, Narantuya D, Watanabe T, Masuda J, Kobayashi S, Kim SU, Yamaguchi S. 2010. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model. J Neurosci Res 88:1017-1025
36. Waterhouse EG, An JJ, Orefice LL, Baydyuk M, Liao GY, Zheng K, Lu B, Xu B. 2012. BDNF promotes differentiation and maturation of adult-born neurons through GABAergic transmission. J Neurosci 32:14318-14330.
37. Wegner M, Stolt CC. 2005. From stem cells to neurons and glia: A Soxist's view of neural development. Trends Neurosci 28:583-588.
38. Weiss ML, Troyer DL. 2006. Stem cells in the umbilical cord. Stem Cell Rev 2:155-162.
39. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR. 2008. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26:2865-2874.
40. Wilson M, Koopman P. 2002. Matching SOX: Partner proteins and cofactors of the SOX family of transcriptional regulators. Curr Opin Genet Dev 12:441-446.